P. Fanti et al., Serum levels and metabolic clearance of the isoflavones genistein and daidzein in hemodialysis patients, J AM S NEPH, 10(4), 1999, pp. 864-871
Genistein and daidzein are biologically active isoflavones that are especia
lly abundant in soybeans. After intestinal absorption, circulating genistei
n and daidzein are eliminated primarily by the kidneys. This study was unde
rtaken to assess the metabolism of genistein and daidzein in patients with
end-stage renal disease (ESRD) on hemodialysis therapy, and to test whether
this treatment modality can replace the lack of kidney function, with resp
ect to the elimination of the isoflavones. Twenty-three hemodialysis patien
ts and 10 healthy subjects were studied. While consuming a self-selected lo
w isoflavone diet, baseline blood levels were undetectable in eight of 10 h
ealthy subjects and in 14 of 23 dialysis patients. The remaining participan
ts had detectable levels, with the nine dialysis patients displaying much h
igher blood concentrations than the two healthy control subjects. After the
evening intake of one dose of an isoflavone-rich soy protein isolate drink
, the early morning blood levels of genistein and daidzein were higher in s
even dialysis patients than in eight healthy subjects (genistein 1271 +/- 3
21 versus 425 +/- 104, P < 0.05; daidzein 1304 +/- 352 versus 292 +/- 78, P
< 0.05). The brood clearance of the isoflavones was studied in two healthy
subjects and in three dialysis patients. Genistein and daidzein were elimi
nated within 2 d in the healthy subjects, but had not returned to baseline
in two of three ESRD patients, 7 d after intake. The half-life of both comp
ounds was estimated to be 10-fold longer in the ESRD patients than in the h
ealthy subjects. Finally, genistein and daidzein levels were measured befor
e and after dialysis in five patients, both while on their regular diet and
after one dose of a soy protein isolate drink. In both instances, the dial
ysis treatment did not affect the blood isoflavone levels. In conclusion, a
pproximately one-third of hemodialysis patients eating the standard America
n renal diet experience high blood levels of the isoflavones genistein and
daidzein, while the remaining two-thirds have undetectable levels. After in
gestion of isoflavone-rich food such as soy products, all patients have det
ectable levels that remain very high for several days due to lack of renal
excretion.